The Carnitine Palmitoyl-Transferase 2 Cascade Hypothesis for Alzheimer’s Disease

Hiskias G. Keizer*, Ruud Brands, Ronald S. Oosting, Willem Seinen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Despite decades of intense research, the precise etiology of Alzheimer’s disease (AD) remains unclear. In this hypothesis, we present a new perspective on this matter by identifying carnitine palmitoyl transferase-2 (CPT2) as a central target in AD. CPT2 is an enzyme situated within the inner mitochondrial membrane, playing a crucial role in beta-oxidation of fatty acids. It exhibits high sensitivity to hydrogen peroxide. This sensitivity holds relevance for the etiology of AD, as all major risk factors for the disease share a commonality in producing an excess of hydrogen peroxide right at this very mitochondrial membrane. We will explain the high sensitivity of CPT2 to hydrogen peroxide and elucidate how the resulting inhibition of CPT2 can lead to the characteristic phenotype of AD, thus clarifying its central role in the disease’s etiology. This insight holds promise for the development of therapies for AD which can be implemented immediately.

Original languageEnglish
Pages (from-to)553-558
Number of pages6
JournalJournal of Alzheimer's Disease
Volume97
Issue number2
DOIs
Publication statusPublished - 16 Jan 2024

Keywords

  • Alzheimer’s disease
  • AMP-kinase pathway dependent integrated stress response
  • carnitine palmitoyl transferase 2
  • CPT2
  • hydrogen peroxide
  • hypoxia
  • longevity
  • radical oxygen species

Fingerprint

Dive into the research topics of 'The Carnitine Palmitoyl-Transferase 2 Cascade Hypothesis for Alzheimer’s Disease'. Together they form a unique fingerprint.

Cite this